Lecanemab Real-World Safety: Duke Health Study Insights for Alzheimer’s Patients

A recent breakthrough study from Duke Health, published on August 10, 2026, provides much-needed clarity on how lecanemab performs when administered outside the strict confines of a trial. For families and patients navigating this new landscape, the findings offer both reassurance and a roadmap for safety.